Schedule 13G ownership disclosure
COCRYSTAL PHARMA INC
Security class unavailable · CUSIP: 19188J300
Event date: 2021-05-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,740,000
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-21-000090
- Form type
- SC 13G
- Filer
- Cocrystal Pharma, Inc.
- CIK
- CIK 1412486
- Filed
- May 12, 2021
- Reporting period
- May 05, 2021
- Description
- Schedule 13G beneficial ownership